Yoshitaka Narita

National Cancer Centre Japan — Japan

Medicine · Health Sciences

55h-index10.4kcitations550works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(335), Brain Metastases and Treatment(92), Radiomics and Machine Learning in Medical Imaging(51), Meningioma and schwannoma management(46), Cancer, Hypoxia, and Metabolism(39)

Publications549 total

A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
The Lancet Oncology·2025· 1 cited
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making
The Lancet Oncology·2025· 1 cited
Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models
Radiotherapy and Oncology·2025
10047-CO-1 A Predictive Model of Malignant Transformation in IDH-Mutant LGG to Support Clinical Decision-Making
Neuro-Oncology Advances·2025Open Access
10244-CS-24 Current status and challenges of adult medulloblastoma treatment
Neuro-Oncology Advances·2025Open Access
10184-NQPC-7 Prognostic Significance of Preoperative Constipation in Patients with Malignant Glioma: Reproducibility Confirmed by External Validation
Neuro-Oncology Advances·2025Open Access
10199-CS-20 IDH-mutant glioma patients treated with Vorasidenib: rationale, design and trial in progress of the Vorasidenib Expanded Trial in Japan
Neuro-Oncology Advances·2025Open Access
10197-CS-19 A global, randomized, double-blinded, Phase 3 study of Vorasidenib versus placebo in patients with adult-type diffuse glioma with an IDH1/2 mutation (INDIGO): updated data from the Japan subgroup analysis
Neuro-Oncology Advances·2025Open Access
Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
Neuro-Oncology·2025Open Access
Development and validation of a prognostic nomogram for survival in patients with brain metastases from colorectal cancer
Scientific Reports·2025Open Access
Multi-modal profiling and targeting of the tumor microenvironment in central nervous system lymphoma
Blood·2025Open Access
Whole-genome analysis reveals shared early genetic alterations and subtype-specific immune evasion pathways in intravascular large B-cell lymphoma and immune-privileged large B-cell lymphoma
Blood·2025
SURG-09. Predicting Malignant Transformation in IDH-Mutant WHO Grade 2 Gliomas Using a Simplified Volume-Based Model
Neuro-Oncology·2025
QOL-04. Health-related quality of life decline precedes radiographic progression in malignant glioma: A retrospective study in bevacizumab-treated patients
Neuro-Oncology·2025
PATH-22. Characteristics of various comprehensive genomic profiling tests for central nervous system tumors in Japan since 2023
Neuro-Oncology·2025Open Access
CTNI-75. SAFETY AND EFFICACY OF METFORMIN AND TEMOZOLOMIDE TARGETING CANCER STEM CELLS FOR NEWLY DIAGNOSED GLIOBLASTOMA
Neuro-Oncology·2025Open Access
PATH-34. Assessment of BRAF alterations and recommended treatments in CNS tumors with BRAF alterations
Neuro-Oncology·2025Open Access
CTNI-16. PATIENT BACKGROUNDS ASSOCIATED WITH THE PROLONGED EFFECTIVENESS OF TIRABRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RESULTS FROM THE ROSETTA STUDY
Neuro-Oncology·2025Open Access
Chromosome 15q15 Deletion Drives Brain Metastasis in NSCLC
Journal of Thoracic Oncology·2025
Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma
Future Oncology·2025Open Access
page 1 of 28Next →

Frequent Co-authors

Soichiro Shibui(23), Koichi Ichimura(19), Ryo Nishikawa(18), Motoo Nagane(15), Yuko Matsushita(14), Akitake Mukasa(13), Shintaro Fukushima(11), Yasuji Miyakita(11), Takamasa Kayama(11), Hideyuki Arita(10), Nobuhito Saito(10), Kazuhiko Mishima(10), Taishi Nakamura(9), Hirokazu Takami(9), Yonehiro Kanemura(9), Makoto Ohno(8), Masahiro Nonaka(7), Chifumi Kitanaka(7), Toshihiro Kumabe(7), Kazuhiko Sugiyama(7)